#Pluristem successful in treating 7 year old girl
Pluristem Therapeutics, an Israeli biotech focusing on stem cells from the placenta, has announced that their proprietary treatment has reversed..

Conference producer interested in animal health, stem cells, vaccines and biopharma. I'll post on a variety of topics - I hope you enjoy my posts and find them interesting!
This week, Osiris Therapeutics received approval from Canadian regulatory officials for its Prochymal therapy. Osiris says the approval marks..
Pluristem Therapeutics, an Israeli biotech focusing on stem cells from the placenta, has announced that their proprietary treatment has reversed..
Scientists at UC Davis are gearing up for a human trial using stem cells to combat HIV, the virus that causes AIDS. By engineering multiple types..
The University of Michigan could lose its share of $40M if local lawmakers have their way. The dispute, which began over reporting of embryonic..
A few months ago, I blogged about a man who became the second person ever to received a synthetic windpipe. Sadly, Christopher Lyles died Monday,..
Harvard scientists, in collaboration with Mass General Hospital, may have discovered a new kind of stem cell that controls production of eggs..
For the second time in this (pre-) election cycle, the issue of stem cells has broken into the national debate. This time, it focuses not on..
Alzheimer's is a debilitating disease that affects 5.4 million people and costs $183 billion per year. It is the 6th biggest killer in the US,..
Nearly a year ago, 60 Minutes ran a story on fake stem cell treatments being targeted at terminally ill patients. Last week, three men were taken..
A scientist in Sweden has successfully transplanted an artificial windpipe with the help of autologous stem cells. Read the full story here...
Stem cell research on apes made news a few weeks ago when a British agency called for reforms in the way we use animals to test human health..
© terrapinn holdings ltd. MMX | images courtesy of SXC | terms & conditions | privacy | log in
